Xiamen Amoytop Biotech News

Xiamen Amoytop Biotech: Progress Announcement on Signing Exclusive License Agreement

Jul 25 12:00 ET

Xiamen Amoytop Biotech: Investor Relations Activity Record (July 17, 2024)

Jul 17 06:28 ET

Xiamen Amoytop Biotech: Announcement on Director's shareholding reduction results and voluntary commitment not to reduce company's shareholding during specific period.

Jul 15 12:00 ET

Xiamen Amoytop Biotech: Investor Relations Activity Record (July 11, 2024)

Jul 11 21:30 ET

Xiamen Amoytop Biotech: Announcement on the approval of the drug clinical trial approval letter for the newly approved indications of Pegintron.

Jul 7 12:00 ET

Xiamen Amoytop Biotech: Investor Relations Activity Record (June 18, 2024)

Jun 18 05:31 ET

Xiamen Amoytop Biotech: Director's shareholding reduction announcement.

Jun 14 12:00 ET

Xiamen Amoytop Biotech: Investor Relations Activity Schedule (May 22, 2024)

May 22 21:35 ET

Xiamen Amoytop Biotech: Investor Relations Activity Schedule (May 16, 2024)

May 16 20:35 ET

Xiamen Amoytop Biotech: 2023 Annual Equity Distribution Implementation Notice

May 16 12:00 ET

Xiamen Amoytop Biotech: Announcement on participating in the 3rd “Improving Quality, Efficiency, and Reward” special session of the Science and Technology Innovation Board's 2023 Group Results Briefing

May 8 12:00 ET

Xiamen Amoytop Biotech: Voluntary disclosure notice on the proposed inclusion of additional indications for Pegobin in the priority review process

May 7 12:00 ET

Xiamen Amoytop Biotech: Announcement on participating in the 2023 Annual Report Performance Briefing and Online Investor Reception Day for Listed Companies in the Xiamen Area

May 6 12:00 ET

Xiamen Amoytop Biotech: 2023 Annual General Meeting of Shareholders Legal Opinions

Apr 29 12:00 ET

Xiamen Amoytop Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

Apr 29 12:00 ET

Tebao Biotech: Report for the first quarter of 2024

Apr 22 12:00 ET

Tebao Biotech: Investor Relations Activity Record Form (2023 Biological Products Special Group Performance Briefing)

Apr 15 21:30 ET

Tebao Biotech: 2023 Annual General Meeting of Shareholders Meeting Information

Apr 15 12:00 ET

Tebao Biotech: Guojin Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Tebao Biotech

Apr 15 12:00 ET

Tebao Biotech: Voluntary Disclosure Notice on Passing High-tech Enterprise Certification

Apr 15 12:00 ET